Topical capsaicin in burning mouth syndrome

Phase 3

Completed

• Conditions: burning mouth syndrome; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12608000235303
• Lead Sponsor: Sao Paulo University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-05-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

burning mouth syndrome, no recent use of other drugs

Exclusion Criteria

diabetic patients, anemia, candida infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
relief of symptoms assessed through a visual analogue scale and a questionnaire of an overall effect perceived[4 weeks after starting medication or placebo, 8 weeks at the ending of drug administration and 12 weeks, four weeks after drug discontinuation.]

Secondary Outcome Measures

Name	Time	Method
lasting of the benefits achieved - relief of symptoms, measured through visual analogue scale and a questionnaire of an overall effect perceived[six months after discontinuation of drug treatment]